Hi kens. I think it is important to note that increase of new patients from Q4 to Q1 despite being a seasonly weaker quarter in conjunction with the improved discountuation rates means we might see a figure higher than that. For example if we could expect 4% patient growth (quarter on quarter) that's closer to 17% increase over a year due to compounding affect. I don't know if we'll hit 4% relative increase each quarter, but I would think 15% may be achievable with the 30% increase in sales force and the more stable existing cohort of patients.
NEU Price at posting:
$12.75 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)